Evaluation of Glucose Levels Using FreeStyle Libre 3 Device in Adults with Type 1 or Type 2 Diabetes With or Without Gastroparesis

What this Trial Is About

Researchers are comparing glucose measurements using a real-time continuous glucose monitor FreeStyle Libre 3 sensor in adults with type 1 or type 2 diabetes who either have gastroparesis or do not have gastroparesis. The study aims to understand differences in glucose control and to explore whether gastroparesis affects glucose patterns. This information may help develop a new tool to detect early gastroparesis in diabetic patients. Participants in both groups will use the FreeStyle Libre 3 sensor to monitor glucose levels continuously for 28 days. During this period, they will also undergo two standardized meal challenges using a balanced nutritional drink to assess glucose responses. The study will monitor episodes of high and low blood sugar and collect questionnaire data on gastroparesis symptoms and gastrointestinal quality of life. Throughout the study, participants will be assessed for various glucose metrics such as time spent within target glucose ranges and glucose variability. Questionnaires will evaluate symptom severity and quality of life related to gastroparesis. The study will last for 28 days of glucose monitoring, including the meal challenge visits, to gather comprehensive data on glucose control and its association with gastroparesis.

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes